Yazar "Erol, Selvinaz" için listeleme
-
Can Age at Diagnosis and Sex Improve the Performance of the American Thyroid Association Risk Stratification System for Prediction of Structural Persistent and Recurrent Disease in Patients With Differentiated Thyroid Carcinoma? A Multicenter Study
Zuhur, Sayid Shafi; Ağgül, Hünkar; Çelik, M.; Avcı, U.; Erol, Selvinaz; Kılınç, F.; Altuntaş, Yüksel; Bilen, O.; Elbuken, G.; Topçu, B. (Elsevier B.V., 2022)Objective: Although the age at diagnosis has been suggested as a major determinant of disease-specific survival in the recent TNM staging system, it is not included in the recent American Thyroid Association (ATA) guidelines ... -
The effect of gender on response to antithyroid drugs and risk of relapse after discontinuation of the antithyroid drugs in patients with Graves' hyperthyroidism: a multicentre study
Zuhur, Sayid Shafi; Yıldız, İsmail; Altuntaş, Yüksel; Bayraktaroğlu, Taner; Erol, Selvinaz; Şahin, Serdar; Kadıoğlu, Pınar; Elbüken, Gülşah; Topçu, Birol (Via Medica, 2020)Introduction: The outcome of medical treatment in patients with Graves' disease (GD) is generally difficult to predict. In this study, we examined the hypothesis that gender may affect the outcome of treatment with antithyroid ... -
External Validation of the GREAT Score in Turkish Patients with Graves' Hyperthyroidism Treated with the Titration Regimen Method of Antithyroid Drugs: A Multicenter Study
Zuhur, Sayid Shafi; Elbüken, Gülşah; Yıldız, İsmail; Kadıoğlu, Pınar; Erol, Selvinaz; Şahin, Serdar; Altuntaş, Yüksel (Georg Thieme Verlag Kg, 2019)Recently, the Graves & apos; Recurrent Events After Therapy score (GREAT) was proposed as a useful tool to predict relapse before starting antithyroid drugs (ATD) in patients with Graves & apos; disease (GD). Therefore, ...